CPI-444
产品编号: DC10527
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
CPI-444 是一种有效的选择性 A2A 受体 (A2AR) 抑制剂，诱导抗肿瘤反应。
| Cas No.: |
1202402-40-1 |
| 名称: |
(S)-7-(5-methylfuran-2-yl)-3-((6-(((tetrahydrofuran-3-yl)oxy)methyl)pyridin-2-yl)methyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine |
| 别名: |
CPI-444,CPI 444,CPI444 |
| SMILES: |
NC1=NC2=C(N=NN2CC3=NC(CO[C@H]4CCOC4)=CC=C3)C(C5=CC=C(O5)C)=N1 |
| 分子式: |
C20H21N7O3 |
| 分子量: |
407.43 |
| 纯度: |
|
| 保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: |
|
| In Vivo: |
|
| In Vitro: |
|
| References: |
CPI-444 is an orally administered antagonist of the adenosine A2A receptor. It is designed to block the action of adenosine that is produced by tumors. CPI-444 blocks adenosine from binding to the A2A receptor. Adenosine suppresses the anti-tumor activity of T cells and other immune cells. |
| Kinase Assay: |
|
| Cell Assay: |
|
| Animal Administration: |
|
| References: |
|
MSDS
COA
| LOT NO. |
DOWNLOAD |
|
|
| 2018-0101 |
|
询盘
